醫材產品生物相容與 安全性的考量 -...

57
醫材產品生物相容與 安全性的考量 黎莉婷 方策科技股份有限公司 2017.3.28 2017生醫產業人材培訓課程

Upload: doque

Post on 17-Mar-2018

268 views

Category:

Documents


13 download

TRANSCRIPT

  • 2017.3.28

    2017

  • National Taipei University of Technology

    2

    Safety

  • National Taipei University of Technology

    3

    (biocompatibility) : The quality of not having toxic or injurious effects on biological systems

    (systematic response)

    (cellular response)

    (tissue response)

    (local response)

  • National Taipei University of Technology

    4

    - ISO 10993 http://www.iso.org/iso/iso_catalogue.htm- ASTM F748-95 http://www.astm.org

    - FDA Guidance documents (G95-1) http://www.fda.gov/cdrh/g951.html

    - CNS 14393:2004 http://www.cnsonline.com.tw/

    CNS 14393FDA (G95-1)ISO 10993

  • National Taipei University of Technology

    ISO 10993

    5

    ISO 10993 Biological evaluation of medical devices

    ()

  • National Taipei University of Technology

    ISO 10993

    6

    ISO 10993 :

  • National Taipei University of Technology

    ISO 10993

    7

  • National Taipei University of Technology

    ISO 10993

    8

    /

    ISO 10993-8 ISO 10993-12

    ISO 10993-1

    ISO 10993-2

    ///ISO 10993-9 ISO 10993-13 ISO 10993-14 ISO 10993-15 /ISO 10993-16 ISO 10993-17 ISO 10993-18

    ISO 10993-7

    ISO 10993-3 ISO 10993-4 ISO 10993-5 ISO 10993-6 ISO 10993-10 ISO 10993-11

  • National Taipei University of Technology

    9

    :

  • National Taipei University of Technology

    :

    10

    ISO 10993

    ()

    //

  • National Taipei University of Technology

    :

    11

    A. (Limited)24

    B. (Prolonged)24~30

    C. (Permanent)30

  • National Taipei University of Technology

    12

    (ISO 10993-5 ) (ISO 10993-11) (ISO 10993-11) (ISO 10993-10) (ISO 10993-10) (ISO 10993-10) (ISO 10993-4) (ISO 10993-6)

    (ISO 10993-11) (ISO 10993-3) (ISO 10993-3) (ISO 10993-9)

    ? ?

  • National Taipei University of Technology

    ISO 10993

    13

    FDA + ISO additional test for FDA

  • National Taipei University of Technology

    14

    ISO 10993-1

  • ()

    CytotoxicityISO10993-5

  • National Taipei University of Technology

    16

    ISO 10993-5 Test for in vitro Cytotoxicity

    (L929 3T3)

    ? ?

    >24

    /

    (Cytotoxicity)

  • National Taipei University of Technology

    17

    (Filter diffusion test)

    (Direct contact test)

    (Elution test)

    : ()

    /

    0123

    (Agar diffusion test)

    (0.45m)

  • ()

    IrritationISO10993-10

  • National Taipei University of Technology

    19

    ISO 10993-10 Test for Irritation and Delayed-type Hyperseneitivity

    (2Kg)

    (

    ()

    (Irritation)

  • National Taipei University of Technology

    20

    12345

    12345

    12345

    12345

    0.2ml

    4

    ()

    ()

    25mm2

    25mm2

    25mm2

    25mm2

    (Skin irritation)

    (Intracutance reactivity)

  • ()

    SensitizationISO10993-10

  • National Taipei University of Technology

    (1/2)

    22

    ISO 10993-10 Test for Irritation and Delayed-type Hyperseneitivity

    (300~500g)

    -: (48h)(24h)

    -: 33

    /

    (Hyperseneitivity)

  • National Taipei University of Technology

    23

    10SLS

    +

    8cm2 ()

    1

    2

    3

    7 day

    48h

    14 day

    24h

    ABC

    +

    +

    0.1ml

    6h

    24h

    6h

    24h

    6h

    24h 14day

    6h6h

    24h

    6h

    24h

    6h

    24h

    6h

    24h

    6h

    24h

    6h

    (Bueher test) (maximization)

  • Implant EffectsISO10993-6

  • 1. ()24h

    2. ()24h

  • ISO 10993-6 Tests for local effects after implantation

    (Subcutaneous)

    (Muscle)

    (Bone)

    (12)

    (12)

    Muscle tissue from negative and positive reacting implants.

    Minimal response

    Severe response

    http://www.devicelink.com/mddi/archive/98/08/013.html

  • ():

    () :

  • Systemic EffectsISO10993-11

  • 1.

    2. 30d30d()

    3. 30d30d

  • ()

    ISO 10993-11 Tests for systemic toxicity

    (acute toxicity) : < 24 hours (subacute) : 14-28 days (subacute/subchronictoxicity) : up to 90 days (chronic toxicity) : > 90 days

    (oral) (dermal) (inhalation) (intravenous) (intraperitoneal)

    :

  • /

  • Hemocompatibility

    ISO10993-4

  • ()(

    )(thrombogenicity)(

    )

    ASTM F75616((NIH)

    Autian)()

    (

    ELISA)C3aSC5b-9

    ASTM F206519ASTM F1984

  • GenotoxicityISO10993-3

  • In vitro Ames test In vitro Chromosomal aberration TKIn vitro Mouse lymphoma In vivo micronucleus

    DNA

    ISO 10993-3 Tests for genotoxicity, carcinogenicity and reproductive toxicity

    (mutagenicsubstancemutagen)(carcinogenicity)

    (ISO 10993OEDC )

    OECD : Organisation for Economic Co-operation and Development)

  • Ames

    Salmonella typhimuriumhis

    DNA DNA

  • CarcinogenicityISO10993-3

  • In vivo bioassay

    Species: rat, mouse

    Two year duration

    Multiple dose groups

    Histological tissue examination

    Statistical analysis

    Risk assessment

  • Re p r o d u c t i v e a n d d e v e l o p m e n t a l t o x i c i t y

    ISO10993-3

  • 1

    2 ()

    3

  • ISO10993-

  • ISO 10993-1

  • - MEM elution method

    ISO10993-5 L929

    -

    ISO10993-4ASTM

    - -

    ISO10993-10

    - -

    ISO10993-10()

    -

    ISO10993-10

    -

    ISO10993-11

    /- /

    ISO10993-11(14~90)

    -

    ISO10993-11(>6)

    - - LAL Test

    USPLAL test

    - - - - TK

    ISO10993-3DNA

    - - -

    ISO10993-6

  • National Taipei University of Technology

    52

    ISO 10993-1 6 :

    Equivalent

    ISO 10993

  • National Taipei University of Technology

    53

    ISO 10993-1

    ?

    ?

    1. 2.

    /

    /

    ISO 10993

    ()

    ?

    1.2.3.

    ?

  • National Taipei University of Technology

    54

    2

    2

    -

    -

    -

  • /

  • A.

    B.

    C.

    D.

    E.

    F.

  • ~Thankyou~